Affiliation:
1. University of California Los Angeles
Abstract
Abstract
Parkinsonian disorders, including Parkinson's disease (PD), multiple system atrophy (MSA), dementia with Lewy body (DLB), corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP) are often misdiagnosed due to overlapping symptoms and the absence of precise biomarkers. Furthermore, there are no current methods to ascertain the progression and conversion of prodromal conditions such as REM behavior disorder (RBD). Extracellular vesicles (EVs), containing a mixture of biomolecules, have emerged as potential sources for parkinsonian diagnostics. However, inconsistencies in previous studies have left their diagnostic potential unclear. We conducted a meta-analysis, following PRISMA guidelines, to assess the diagnostic accuracy of general EVs isolated from various bodily fluids, including cerebrospinal fluid (CSF), plasma, serum, urine or saliva, in differentiating patients with parkinsonian disorders from healthy controls (HCs). The meta-analysis included 21 studies encompassing 1,285 patients with PD, 24 with MSA, 105 with DLB, 99 with PSP, 101 with RBD, and 783 HCs. Analyses were conducted only for patients with PD vs. HCs, given the limited number for other comparisons. Using bivariate and hierarchal receiver operating characteristics (HSROC) models, the meta-analysis revealed moderate diagnostic accuracy in distinguishing PD from HCs, with substantial heterogeneity and publication bias detected. The trim-and-fill method revealed at least two missing studies with null or low diagnostic accuracy. CSF-EVs showed better overall diagnostic accuracy, while plasma-EVs had the lowest performance. General EVs demonstrated higher diagnostic accuracy compared to CNS-originating EVs, which are more time-consuming, labor- and cost-intensive to isolate. In conclusion, while holding promise, utilizing biomarkers in general EVs for PD diagnosis remains unfeasible due to existing challenges. The focus should shift toward harmonizing the field through standardization, collaboration, and rigorous validation. Current efforts by ISEV aim to enhance the accuracy and reproducibility of EV-related research through rigor and standardization, aiming to bridge the gap between theory and practical clinical application.
Publisher
Research Square Platform LLC
Reference109 articles.
1. Parkinson disease;Poewe W;Nat Rev Dis Primers,2017
2. Diagnosis and Treatment of Parkinson Disease: A Review;Armstrong MJ;JAMA,2020
3. Surguchov A (2022) Biomarkers in Parkinson’s Disease In Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice, Peplow PV, Martinez B, Gennarelli AT, eds. Humana, Springer.
4. Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis;Rizzo G;Neurology,2016
5. How valid is the clinical diagnosis of Parkinson's disease in the community?;Schrag A;J Neurol Neurosurg Psychiatry,2002